Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta

BACKGROUND: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker....

Descripción completa

Detalles Bibliográficos
Autores principales: Wranke, Anika, Heidrich, Benjamin, Ernst, Stefanie, Calle Serrano, Beatriz, Caruntu, Florin Alexandru, Curescu, Manuela Gabriela, Yalcin, Kendal, Gürel, Selim, Zeuzem, Stefan, Erhardt, Andreas, Lüth, Stefan, Papatheodoridis, George V., Bremer, Birgit, Stift, Judith, Grabowski, Jan, Kirschner, Janina, Port, Kerstin, Cornberg, Markus, Falk, Christine S., Dienes, Hans-Peter, Hardtke, Svenja, Manns, Michael P., Yurdaydin, Cihan, Wedemeyer, Heiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114528/
https://www.ncbi.nlm.nih.gov/pubmed/25072849
http://dx.doi.org/10.1371/journal.pone.0101002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114528/
https://www.ncbi.nlm.nih.gov/pubmed/25072849
http://dx.doi.org/10.1371/journal.pone.0101002

Ejemplares similares